Uterine Leukocyte Function and Dysfunction: A Hypothesis on the Impact of Endometriosis

American Journal of Reproductive Immunology

Volumn 75, Issue 3, 2016, Pages 411-417

  Parkin, Kirstin L ^a,b   Fazleabas, Asgerally T ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Endometriosis; implantation failure; menstruation; NK cells; regulatory T cells

Indexed keywords

CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE; HUMAN; HUMAN CELL; IMMUNE SYSTEM; INFERTILITY; LEUKOCYTE DISORDER; LEUKOCYTE FUNCTION; MENORRHAGIA; MENSTRUAL CYCLE; NATURAL KILLER CELL; NIDATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; UTERUS DISEASE;

EID: 84977507300     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12487     Document Type: Review

References (59)

1. Clement PB: The pathology of endometriosis: a survey of the many faces of a common disease emphasizing diagnostic pitfalls and unusual and newly appreciated aspects. Adv Anat Pathol 2007; 14:241–260.
2. Eskenazi B, Warner ML: Epidemiology of endometriosis. Obstet Gynecol Clin North Am 1997; 24:235–258.
3. Burney RO, Giudice LC: Pathogenesis and pathophysiology of endometriosis. Fertil Steril 2012; 98:511–519.
4. Sherwin JRA, Sharkey AM, Mihalyi A, Simsa P, Catalano RD, D'Hooghe TM: Global gene analysis of late secretory phase, eutopic endometrium does not provide the basis for a minimally invasive test of endometriosis. Hum Reprod 2008; 23:1063–1068.
5. Jones CJP, Inuwa IM, Nardo LG, Litta P, Fazleabas AT: Eutopic endometrium from women with endometriosis shows altered ultrastructure and glycosylation compared to that from healthy controls–a pilot observational study. Reprod Sci 2009; 16:559–572.
6. Umezawa M, Tanaka N, Tainaka H, Takeda K, Ihara T, Sugamata M: Microarray analysis provides insight into the early steps of pathophysiology of mouse endometriosis model induced by autotransplantation of endometrium. Life Sci 2009; 84:832–837.
7. Donaghay M, Lessey BA: Uterine receptivity: alterations associated with benign gynecological disease. Semin Reprod Med 2007; 25:461–475.
8. Barnhart K, Dunsmoor-Su R, Coutifaris C: Effect of endometriosis on in vitro fertilization. Fertil Steril 2002; 77:1148–1155.
9. Medina MG, Lebovic DI: Endometriosis-associated nerve fibers and pain. Acta Obstet Gynecol Scand 2009; 88:968–975.
10. Wang G, Tokushige N, Russell P, Dubinovsky S, Markham R, Fraser IS: Hyperinnervation in intestinal deep infiltrating endometriosis. J Minim Invasive Gynecol 2009; 16:713–719.
11. Sampson JA: Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927; 3:93–110.43.
12. Gruenwald P: Origin of endometriosis form the mesenchyme of the celomic walls. Am J Obstet Gynecol 1942; 44:470–474.
13. Jubanyik KJ, Comite F: Extrapelvic endometriosis. Obstet Gynecol Clin North Am 1997; 24:411–440.
14. Grümmer R: Translational animal models to study endometriosis-associated infertility. Semin Reprod Med 2013; 31:125–132.
15. Braundmeier AG, Fazleabas AT: The non-human primate model of endometriosis: research and implications for fecundity. Mol Hum Reprod 2009; 15:577–586.
16. Berbic M, Hey-Cunningham AJ, Ng C, Tokushige N, Ganewatta S, Markham R, Russell P, Fraser IS: The role of Foxp3+ regulatory T-cells in endometriosis: a potential controlling mechanism for a complex, chronic immunological condition. Hum Reprod 2010; 25:900–907.
17. Braundmeier A, Jackson K, Hastings J, Koehler J, Nowak R, Fazleabas A: Induction of endometriosis alters the peripheral and endometrial regulatory T cell population in the non-human primate. Hum Reprod 2012; 27:1712–1722.
18. Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S, Panina-Bordignon P, Manfredi AA, Rovere-Querini P: Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol 2009; 175:547–556.
19. Chuang P-C, Wu M-H, Shoji Y, Tsai S-J: Downregulation of CD36 results in reduced phagocytic ability of peritoneal macrophages of women with endometriosis. J Pathol 2009; 219:232–241.
20. Takamura M, Koga K, Izumi G, Hirata T, Harada M, Hirota Y, Hiraike O, Fujii T, Osuga Y: Simultaneous detection and evaluation of four subsets of CD4+ T lymphocyte in lesions and peripheral blood in endometriosis. Am J Reprod Immunol 2015; 74:480–486.
21. Jones RK, Bulmer JN, Searle RF: Phenotypic and functional studies of leukocytes in human endometrium and endometriosis. Hum Reprod Update 1998; 4:702–709.
22. Nagler A, Lanier LL, Cwirla S, Phillips JH: Comparative studies of human FcRIII-positive and negative natural killer cells. J Immunol 1989; 143:3183–3191.
23. Tang AW, Alfirevic Z, Quenby S: Natural killer cells and pregnancy outcomes in women with recurrent miscarriage and infertility: a systematic review. Hum Reprod 2011; 26:1971–1980.
24. King A, Loke YW: On the nature and function of human uterine granular lymphocytes. Immunol Today 1991; 12:432–435.
25. Jokhi PP, King A, Sharkey AM, Smith SK, Loke YW: Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J Immunol 1994; 153:4427–4435.
26. Dosiou C, Giudice LC: Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 2005; 26:44–62.
27. Kalkunte SS, Mselle TF, Norris WE, Wira CR, Sentman CL, Sharma S: Vascular endothelial growth factor C facilitates immune tolerance and endovascular activity of human uterine NK cells at the maternal-fetal interface. J Immunol 2009; 182:4085–4092.
28. Vacca P, Moretta L, Moretta A, Mingari MC: Origin, phenotype and function of human natural killer cells in pregnancy. Trends Immunol 2011; 32:517–523.
29. Verma S, Hiby SE, Loke YW, King A: Human decidual natural killer cells express the receptor for and respond to the cytokine interleukin 15. Biol Reprod 2000; 62:959–968.
30. Thiruchelvam U, Wingfield M, O'Farrelly C: Natural killer cells: key players in endometriosis. Am J Reprod Immunol 2015; 74:291–301.
31. Clifford K, Flanagan AM, Regan L: Endometrial CD56+ natural killer cells in women with recurrent miscarriage: a histomorphometric study. Hum Reprod 1999; 14:2727–2730.
32. Lachapelle MH, Miron P, Hemmings R, Roy DC: Endometrial T, B, and NK cells in patients with recurrent spontaneous abortion. Altered profile and pregnancy outcome. J Immunol 1996; 156:4027–4034.
33. Tuckerman E, Laird SM, Prakash A, Li TC: Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod 2007; 22:2208–2213.
34. Quenby S, Bates M, Doig T, Brewster J, Lewis-Jones DI, Johnson PM, Vince G: Pre-implantation endometrial leukocytes in women with recurrent miscarriage. Hum Reprod 1999; 14:2386–2391.
35. Michimata T, Ogasawara MS, Tsuda H, Suzumori K, Aoki K, Sakai M, Fujimura M, Nagata K, Nakamura M, Saito S: Distributions of endometrial NK cells, B cells, T cells, and Th2/Tc2 cells fail to predict pregnancy outcome following recurrent abortion. Am J Reprod Immunol 2002; 47:196–202.
36. Fukui K, Yoshimoto I, Matsubara K, Hori R, Ochi H, Ito M: Leukocyte function-associated antigen-1 expression on decidual natural killer cells in patients with early pregnancy loss. Mol Hum Reprod 1999; 5:1083–1088.
37. Matteo MG, Greco P, Rosenberg P, Mestice A, Baldini D, Falagario T, Martino V, Santodirocco M, Massenzio F, Castellana L, Specchia G, Liso A: Normal percentage of CD56bright natural killer cells in young patients with a history of repeated unexplained implantation failure after in vitro fertilization cycles. Fertil Steril 2007; 88:990–993.
38. Tuckerman E, Mariee N, Prakash A, Li TC, Laird S: Uterine natural killer cells in peri-implantation endometrium from women with repeated implantation failure after IVF. J Reprod Immunol 2010; 87:60–66.
39. Klentzeris LD, Bulmer JN, Liu DT, Morrison L: Endometrial leukocyte subpopulations in women with endometriosis. Eur J Obstet Gynecol Reprod Biol 1995; 63:41–47.
40. Fernández-Shaw S, Clarke MT, Hicks B, Naish CE, Barlow DH, Starkey PM: Bone marrow-derived cell populations in uterine and ectopic endometrium. Hum Reprod 1995; 10:2285–2289.
41. Jones RK, Bulmer JN, Searle RF: Immunohistochemical characterization of stromal leukocytes in ovarian endometriosis: comparison of eutopic and ectopic endometrium with normal endometrium. Fertil Steril 1996; 66:81–89.
42. Giuliani E, Parkin KL, Lessey BA, Young SL, Fazleabas AT: Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis. Am J Reprod Immunol 2014; 72:262–269.
43. Nowak I, Płoski R, Barcz E, Dziunycz P, Kamiński P, Kostrzewa G, Milewski ?, Roszkowski PI, Senitzer D, Malejczyk J, Ku?nierczyk P: KIR2DS5 in the presence of HLA-C C2 protects against endometriosis. Immunogenetics 2015; 67:203–209.
44. Tian X, Zhang L, Zhang X: Lymphocytes and perforin expression in endometrium during the menstrual cycle. Chin Med J (Engl) 2000; 113:930–933.
45. Igarashi T, Konno R, Okamoto S, Moriya T, Satoh S, Yajima A: Involvement of granule-mediated apoptosis in the cyclic changes of the normal human endometrium. Tohoku J Exp Med 2001; 193:13–25.
46. Pipkin ME, Lieberman J: Delivering the kiss of death: progress on understanding how perforin works. Curr Opin Immunol 2007; 19:301–308.
47. King A, Wellings V, Gardner L, Loke YW: Immunocytochemical characterization of the unusual large granular lymphocytes in human endometrium throughout the menstrual cycle. Hum Immunol 1989; 24:195–205.
48. Berbic M, Fraser IS: Immunology of normal and abnormal menstruation. Womens Health (Lond Engl) 2013; 9:387–395.
49. Biswas Shivhare S, Bulmer JN, Innes BA, Hapangama DK, Lash GE: Menstrual cycle distribution of uterine natural killer cells is altered in heavy menstrual bleeding. J Reprod Immunol 2015; 112:88–94.
50. Smith-Garvin JE, Koretzky GA, Jordan MS: T cell activation. Annu Rev Immunol 2009; 27:591–619.
51. Flynn L, Byrne B, Carton J, Kelehan P, O'Herlihy C, O'Farrelly C: Menstrual cycle dependent fluctuations in NK and T-lymphocyte subsets from non-pregnant human endometrium. Am J Reprod Immunol 2000; 43:209–217.
52. Raphael I, Nalawade S, Eagar TN, Forsthuber TG: T cell subsets and their signature cytokines in autoimmune and inflammatory diseases. Cytokine 2015; 74:5–17.
53. Sakaguchi S, Miyara M, Costantino CM, Hafler DA: FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010; 10:490–500.
54. Jasper MJ, Tremellen KP, Robertson SA: Primary unexplained infertility is associated with reduced expression of the T-regulatory cell transcription factor Foxp3 in endometrial tissue. Mol Hum Reprod 2006; 12:301–308.
55. Basta P, Majka M, Jozwicki W, Lukaszewska E, Knafel A, Grabiec M, Stasienko E, Wicherek L: The frequency of CD25+CD4+ and FOXP3+ regulatory T cells in ectopic endometrium and ectopic decidua. Reprod Biol Endocrinol 2010; 8:116.
56. Chen S, Zhang J, Huang C, Lu W, Liang Y, Wan X: Expression of the T regulatory cell transcription factor FoxP3 in peri-implantation phase endometrium in infertile women with endometriosis. Reprod Biol Endocrinol 2012; 10:34.
57. Fu B, Tian Z, Wei H: TH17 cells in human recurrent pregnancy loss and pre-eclampsia. Cell Mol Immunol 2014; 11:564–570.
58. Berbic M, Ng CHM, Fraser IS: Inflammation and endometrial bleeding. Climacteric J Int Menopause Soc 2014; 17(Suppl 2):47–53.
59. Arruda MS, Petta CA, Abrão MS, Benetti-Pinto CL: Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women. Hum Reprod 2003; 18:756–759.